Loading viewer...
earnings
Format: PDF earnings
Amgen's Q2 2023 earnings presentation delivered on August 3, 2023, includes forward-looking statements on product performance, acquisitions including Horizon Therapeutics, and financial guidance. The deck covers clinical developments, commercial updates, and strategic initiatives across Amgen's biopharmaceutical portfolio. Risk factors and safe harbor disclosures detail regulatory, manufacturing, and competitive challenges affecting the company's operations.
earnings
18 Pages
Lydall
EDP 9M16 Financial Results 2016
earningsearnings
31 Pages
EDP - Energias de Portugal, S.A.